Geoff Parker

(Mr. Geoffrey Parker)

Currently holds positions in Tricida Inc, ChemoCentryx Inc and Perrigo Company PLC

Positions

Position Company Period
Chief Financial Officer, Senior Vice President Tricida Inc April 1, 2017 -
Independent Director ChemoCentryx Inc Dec. 1, 2009 -
Independent Director Perrigo Company PLC Nov. 7, 2016 -
Independent Director Genomic Health Inc June 21, 2016 - Nov. 8, 2019
Director Sunesis Pharmaceuticals Inc March 23, 2016 - Dec. 31, 2017
Geoff Parker's trades of Allogene Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-05 2025-02-03
S Sale
4,361 -0.3%
1.73
USD 7,545 		4,361 -0.3% 1.73 USD 7,545
2024-03-06 2024-01-30
B Purchase
190 +0.0%
3.60
USD 683 		190 +0.0% 3.60 USD 683
2023-07-31 2023-07-27
B Purchase
685,025 +199.7%
0.73
USD 500,000 		685,025 +199.7% 0.73 USD 500,000
2023-06-14 2023-06-13
B Purchase
10,000 +63.0%
33.06
USD 330,637 		10,000 +63.0% 33.06 USD 330,637
2023-04-12 2023-04-10
B Purchase
303,030 +757.6%
0.83
USD 250,000 		303,030 +757.6% 0.83 USD 250,000
2023-03-07 2023-03-06
B Purchase
5,000 +46.0%
38.05
USD 190,270 		5,000 +46.0% 38.05 USD 190,270
2022-06-14 2022-06-13
B Purchase
25,000 +166.7%
1.45
USD 36,183 		25,000 +166.7% 1.45 USD 36,183
2021-12-17 2021-12-16
B Purchase
5,000 +85.0%
36.85
USD 184,270 		5,000 +85.0% 36.85 USD 184,270
2021-12-16 2021-12-14
B Purchase
20,000 +60.0%
4.94
USD 98,800 		20,000 +60.0% 4.94 USD 98,800
2021-03-18 2021-03-17
B Purchase
2,500 +1666.7%
41.29
USD 103,218 		2,500 +1666.7% 41.29 USD 103,218
2021-03-08 2021-03-05
S Sale
13,330 -51.2%
55.89
USD 744,974 		13,330 -51.2% 55.89 USD 744,974
2021-03-08 2021-03-05
S Sale
16,670 -39.0%
56.78
USD 946,494 		16,670 -39.0% 56.78 USD 946,494
2021-03-08 2021-03-04
S Sale
1,910 -4.3%
60.20
USD 114,980 		1,910 -4.3% 60.20 USD 114,980
2020-12-10 2020-12-10
US Tricida Inc (TCDA)
B Purchase
15,000 +60.0%
6.78
USD 101,700 		15,000 +60.0% 6.78 USD 101,700
2020-05-12 2020-05-12
US Tricida Inc (TCDA)
B Purchase
1,439 +1.5%
31.66
USD 45,559 		1,439 +1.5% 31.66 USD 45,559
2020-05-12 2020-05-12
US Tricida Inc (TCDA)
B Purchase
1,303 +1.4%
30.09
USD 39,207 		1,303 +1.4% 30.09 USD 39,207
2020-05-12 2020-05-11
US Tricida Inc (TCDA)
B Purchase
19,854 +27.4%
30.36
USD 602,767 		19,854 +27.4% 30.36 USD 602,767
2020-05-12 2020-05-11
US Tricida Inc (TCDA)
B Purchase
12,404 +20.7%
29.48
USD 365,670 		12,404 +20.7% 29.48 USD 365,670
2020-03-25 2020-03-23
S Sale
860 -1.7%
38.21
USD 32,863 		860 -1.7% 38.21 USD 32,863
2020-03-25 2020-03-23
S Sale
13,959 -21.7%
37.40
USD 522,008 		13,959 -21.7% 37.40 USD 522,008
2020-03-25 2020-03-23
S Sale
9,181 -12.5%
36.72
USD 337,100 		9,181 -12.5% 36.72 USD 337,100
2020-03-25 2020-03-23
S Sale
2,801 -3.7%
35.32
USD 98,932 		2,801 -3.7% 35.32 USD 98,932
2020-03-25 2020-03-23
S Sale
3,199 -4.0%
34.43
USD 110,147 		3,199 -4.0% 34.43 USD 110,147
2020-03-11 2020-03-10
US Tricida Inc (TCDA)
B Purchase
5,000 +10.0%
29.46
USD 147,300 		5,000 +10.0% 29.46 USD 147,300
2019-06-03 2019-05-30
S Sale
12,815 -15.1%
12.00
USD 153,806 		12,815 -15.1% 12.00 USD 153,806
// ... existing code ... // ... rest of the file ...